Earnings ·
Baird Medical reports $9.9M revenue, up 24.6%, as operating expenses drop to $7.8M and net income turns positive
BDMDBaird Medical Investment Holdings Ltd
Baird Medical Investment Holdings Ltd. reported preliminary unaudited financial results for the six months ended June 30, 2026, showing revenue of approximately $9.9 million, a 24.6% increase from $8.0 million in the prior year period. Gross profit rose 32.0% to $8.6 million with an improved gross margin of 87.0%, driven by geographic sales shifts and licensing revenue. Total operating expenses decreased significantly to $7.8 million from $17.0 million, primarily due to reductions in research and development and general administrative costs. The company achieved net income of approximately $14,000 compared to a net loss of $(11.4) million previously, alongside EBITDA of $1.6 million and adjusted EBITDA of $4.0 million. U.S. revenue contributed approximately 27% of the total, reflecting successful commercial expansion in key territories including Argentina, Vietnam, and Pakistan. Baird Medical is a global medical device company specializing in minimally invasive ablation technologies for solid tumors.